Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 7 (2010), Issue 3 (March)

1. Combination joint-preserving surgery for forefoot deformity in patients with rheumatoid arthritis.
   J Bone Joint Surg Br, 92(3): 380-6. [Abstract] [Full-text]
2. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
   Clin Immunol, 135(1): 118-24. [Abstract] [Full-text]
3. Psychological vulnerability predicts increases in depressive symptoms in individuals with rheumatoid arthritis.
   Nurs Res, 59(2): 140-6. [Abstract] [Full-text]
4. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
   Arthritis Rheum, 62(3): 674-82. [Abstract] [Full-text]
5. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis.
   Arthritis Rheum, 62(3): 705-10. [Abstract] [Full-text]
6. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.
   Arthritis Rheum, 62(3): 683-93. [Abstract] [Full-text]
7. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis.
   Arthritis Rheum, 62(3): 694-704. [Abstract] [Full-text]
8. Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction.
   Arthritis Rheum, 62(3): 732-41. [Abstract] [Full-text]
9. Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A.
   Arthritis Rheum, 62(3): 722-31. [Abstract] [Full-text]
10. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression.
    Arthritis Rheum, 62(3): 896-907. [Abstract] [Full-text]
11. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.
    Ann Rheum Dis, 69(4): 718-22. [Abstract] [Full-text]
12. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.
    Ann Rheum Dis, 69(4): 638-43. [Abstract] [Full-text]
13. Treating rheumatoid arthritis to target: recommendations of an international task force.
    Ann Rheum Dis, 69(4): 631-7. [Abstract] [Full-text]
14. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases.
    Ann Rheum Dis, 69(4): 770-4. [Abstract] [Full-text]
15. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
    Ann Rheum Dis, 69(4): 683-8. [Abstract] [Full-text]
16. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Ann Rheum Dis, 69(4): 671-6. [Abstract] [Full-text]
17. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
    Ann Rheum Dis, 69(4): 666-70. [Abstract] [Full-text]
18. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade.
    Ann Rheum Dis, 69(4): 706-14. [Abstract] [Full-text]
19. Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort.
    Ann Rheum Dis, 69(4): 727-9. [Abstract] [Full-text]
20. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.
    Ann Rheum Dis, 69(4): 730-2. [Abstract] [Full-text]
21. CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis.
    Ann Rheum Dis, 69(4): 723-6. [Abstract] [Full-text]
22. Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.
    Ann Rheum Dis, 69(4): 654-9. [Abstract] [Full-text]
23. FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue.
    Ann Rheum Dis, 69(4): 755-60. [Abstract] [Full-text]
24. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study.
    Ann Rheum Dis, 69(4): 715-7. [Abstract] [Full-text]
25. Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor.
    J Pharmacol Exp Ther, 333(1): 236-43. [Abstract] [Full-text]
26. Mast cells express IL-17A in rheumatoid arthritis synovium.
    J Immunol, 184(7): 3336-40. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.